Gaush Meditech Dividends and Buybacks
Dividend criteria checks 2/6
Gaush Meditech is a dividend paying company with a current yield of 11.69%.
Key information
11.7%
Dividend yield
0%
Buyback Yield
| Total Shareholder Yield | 11.7% |
| Future Dividend Yield | 11.7% |
| Dividend Growth | n/a |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | HK$1.100 |
| Payout ratio | 163% |
Recent dividend and buyback updates
Recent updates
We Think Gaush Meditech (HKG:2407) Can Stay On Top Of Its Debt
Oct 27
The Consensus EPS Estimates For Gaush Meditech Ltd (HKG:2407) Just Fell A Lot
Jul 19Here's What's Concerning About Gaush Meditech's (HKG:2407) Returns On Capital
Jul 16Gaush Meditech Ltd (HKG:2407) Looks Inexpensive After Falling 30% But Perhaps Not Attractive Enough
Jun 19We Think Gaush Meditech (HKG:2407) Can Stay On Top Of Its Debt
Jun 03Revenues Working Against Gaush Meditech Ltd's (HKG:2407) Share Price Following 25% Dive
Apr 05Estimating The Intrinsic Value Of Gaush Meditech Ltd (HKG:2407)
Dec 07A Look At The Fair Value Of Gaush Meditech Ltd (HKG:2407)
Aug 08Gaush Meditech Ltd's (HKG:2407) Business And Shares Still Trailing The Industry
Jun 01Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Too early to tell whether 2407's dividend payments have been stable as they only just started paying a dividend.
Growing Dividend: Too early to tell if 2407's dividend payments are increasing as they only just started paying a dividend.
Dividend Yield vs Market
| Gaush Meditech Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (2407) | 11.7% |
| Market Bottom 25% (HK) | 3.2% |
| Market Top 25% (HK) | 8.0% |
| Industry Average (Medical Equipment) | 3.2% |
| Analyst forecast (2407) (up to 3 years) | 11.7% |
Notable Dividend: 2407's dividend (11.69%) is higher than the bottom 25% of dividend payers in the Hong Kong market (3.25%).
High Dividend: 2407's dividend (11.69%) is in the top 25% of dividend payers in the Hong Kong market (8.03%)
Earnings Payout to Shareholders
Earnings Coverage: With its high payout ratio (162.9%), 2407's dividend payments are not well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its high cash payout ratio (181.9%), 2407's dividend payments are not well covered by cash flows.
Discover strong dividend paying companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/21 12:20 |
| End of Day Share Price | 2025/01/21 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Gaush Meditech Ltd is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Youjue Hu | Morgan Stanley |